RecruitingPhase 3NCT06930625
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Studying Acromegaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Debiopharm International SA
- Intervention
- Debio 4126(drug)
- Enrollment
- 119 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2029
Study locations (30)
- Cedars Sinai Medical Center, Los Angeles, California, United States
- Northwestern University, Chicago, Illinois, United States
- Harvard Medical School, Boston, Massachusetts, United States
- Washington University-School of Medicine, St Louis, Missouri, United States
- Palm Research Center Inc, Las Vegas, Nevada, United States
- The Cleveland Clinic, Cleveland, Ohio, United States
- The Ohio State University, Columbus, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- Thomas Jefferson University, Philadelphia, Pennsylvania, United States
- Medical University Graz, Graz, Austria
- Medizinische Universitaet Wien - Division of Endocrinology and Metabolism, Vienna, Austria
- UZ Gent, Ghent, Belgium
- CETI - Centro de Estudos em Terapias Inovadoras, Curitiba, Brazil
- Nucleo de Pesquisa e Desenvolvimento de Medicamentos (NPDM), Fortaleza, Brazil
- Hospital das Clinicas da UFMG, Minas Gerais, Brazil
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06930625 on ClinicalTrials.govOther trials for Acromegaly
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07037420ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With AcromegalyAlexion Pharmaceuticals, Inc.
- RECRUITINGNCT07179926Effects of Pasireotide Lar Therapy on Bone MetabolismFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGPHASE1NCT07195175Study of MAR002 in Healthy MenMarea Therapeutics
- RECRUITINGNCT06597383The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In AcromegalyIRCCS San Raffaele
- RECRUITINGNANCT06949891KETOgenic Diet Therapy in Patients With ACROmegalyErasmus Medical Center
- RECRUITINGNCT06344650Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.IRCCS San Raffaele
- RECRUITINGNCT05131100Korean Regulatory Post Marketing Surveillance for SomavertPfizer
- ACTIVE NOT RECRUITINGPHASE3NCT05192382A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)Crinetics Pharmaceuticals Inc.